Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
7.22
+0.33 (4.79%)
At close: Jun 6, 2025, 4:00 PM
7.54
+0.32 (4.43%)
After-hours: Jun 6, 2025, 5:41 PM EDT
Jade Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 |
| Dec '24 Dec 31, 2024 |
| Selling, General & Admin | 8.61 |
| Research & Development | 55.87 |
| Operating Expenses | 64.48 |
| Operating Income | -64.48 |
| Interest & Investment Income | 2.32 |
| Other Non Operating Income (Expenses) | -25.2 |
| EBT Excluding Unusual Items | -87.36 |
| Other Unusual Items | -6.6 |
| Pretax Income | -93.96 |
| Net Income | -93.96 |
| Net Income to Common | -93.96 |
| Shares Outstanding (Basic) | 5 |
| Shares Outstanding (Diluted) | 5 |
| EPS (Basic) | -18.79 |
| EPS (Diluted) | -18.79 |
| EBIT | -64.48 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.